| | | | | (Reuters) - AstraZeneca's first respiratory biological medicine Fasenra failed to meet its main target in a second clinical trial treating patients with moderate to very severe chronic obstructive pulmonary disease (COPD). | | |
| | | LONDON/COPENHAGEN (Reuters) - Novo Nordisk said data from a large final-stage study of a pill it hopes will transform the diabetes market proved better at lowering blood sugar levels than Eli Lilly and Boehringer Ingelheim's established Jardiance. | | |
| | | LISBON (Reuters) - Portugal's parliament rejected on Tuesday a bill that would have legalized voluntary euthanasia for terminal patients in the Catholic-majority country by a narrow margin, but it secured enough support to ensure continued debate on the issue. | | |
| | | ZURICH (Reuters) - Roche's bid to keep Merck's cancer blockbuster Keytruda within striking distance got a lift on Tuesday when the Swiss drugmaker said its immunotherapy Tecentriq mixed with chemotherapy boosted lung cancer patients' survival. | | |
| | | ISLAMABAD/NEW DELHI (Reuters) - Philip Morris International Inc and British American Tobacco Plc lobbied Pakistan's government to not implement bigger health warnings on cigarette packs, in what officials say was part of an industry-wide campaign that successfully persuaded Islamabad to water down a proposal designed to save lives. | | |
| | | GENEVA (Reuters) - The World Health Organization assumes 100-300 cases of Ebola in Democratic Republic of Congo between May and July, under a revised response plan to the outbreak that it published on Tuesday. | | |
| | | (Reuters) - WellCare Health Plans Inc said on Tuesday it would buy Meridian Health Plans of Michigan and Illinois for $2.5 billion in cash to become the top Medicaid provider in those states. | | |
| | | (Reuters Health) - It's hard to say whether creams, moisturizers or other preventive measures might help protect workers in many industries from skin damage on their hands that can lead to painful blisters, cracks and infections, a research review suggests. | | |
| | | (Reuters) - Loxo Oncology and Bayer AG said on Tuesday the U.S. Food and Drug Administration granted priority review to their cancer drug and would decide on the marketing application by Nov. 26. | | |
| | | WASHINGTON (Reuters) - In a setback to abortion rights advocates, the U.S. Supreme Court on Tuesday paved the way for Republican-backed restrictions on medication-induced abortions to take effect in Arkansas that could lead to the shuttering of two of the state's three abortion clinics. | | |
|
| |
